Danimer Scientific downgraded to Hold from Buy at TD Cowen

TD Cowen analyst Thomas Boyes downgraded Danimer Scientific to Hold from Buy with a price target of $1, down from $2. The firm expects a more moderate ramp up at the company’s Kentucky facility through 2025 and into 2026. While TD remains positive on Danimer’s underlying technology and is constructive on the recent cost savings initiatives, it sees the stock as “relatively range-bound” ahead of a more marked acceleration of the business in fiscal 2026.